These results, in combination with our previous discovery (18), suggested that Id1 and Id3 may not only be diagnostic and prognostic biomarkers, but also valuable targets for designing biologically appropriate strategies for more effective therapy for SCLC. The gene discussed is ID1; the disease is small cell lung carcinoma.